Kelly Covello
About Kelly Covello
Kelly Covello serves as the Head of Medical at Mirati Therapeutics, a position she has held since 2020. She earned a BS in biology from The College of New Jersey and a PhD in molecular biology and oncology from the University of Pennsylvania School of Medicine.
Work at Mirati Therapeutics
Kelly Covello serves as the Head of Medical at Mirati Therapeutics. She has held this position since 2020. In this role, she is responsible for overseeing medical strategies and initiatives within the organization, contributing to the development of innovative therapies in oncology.
Education and Expertise
Kelly Covello earned a Bachelor of Science degree in biology from The College of New Jersey, where she studied from 1997 to 2001. She further advanced her education at the University of Pennsylvania School of Medicine, obtaining a PhD in molecular biology and oncology from 2001 to 2006. Her academic background provides a strong foundation for her work in the medical field.
Background
Kelly Covello has a robust educational background that includes a focus on biology and molecular biology. Her studies at The College of New Jersey and the University of Pennsylvania School of Medicine have equipped her with the knowledge and skills necessary for her role in the pharmaceutical industry.
Achievements
Since joining Mirati Therapeutics in 2020, Kelly Covello has played a significant role in advancing the company's medical objectives. Her expertise in oncology and molecular biology supports the development of targeted therapies aimed at improving patient outcomes.